The trajectory of companies tied to the drug's past presents a intricate investment scenario . While the initial boom generated substantial profits , generic alternatives have significantly diminished https://escort719896.uzblog.net/copyright-s-flagship-product-and-big-pharma-a-risky-opportunity-55433561